Last reviewed · How we verify

NCT06051630

Effects of Perioperative Administration of Intravenous Lidocaine in Children Operated on for Acute Generalized Peritonitis

Status unknown NA Last updated 25 September 2023
What this trial tests

NA trial testing Lidocaine intravenous in Postoperative Pain in 62 participants. Status unknown.

Timeline
1 October 2023
Primary endpoint
1 November 2023
1 January 2024

Quick facts

Lead sponsorUniversité NAZI BONI
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeother
Enrollment62
Start date1 October 2023
Primary completion1 November 2023
Estimated completion1 January 2024

Drugs / interventions tested

Conditions studied

Sponsor

Université NAZI BONI — full company profile →

Who can join

Adults 6 to 15, any sex, with Postoperative Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Intravenous administration of lidocaine perioperatively after laparotomy for peritonitis could be an interesting alternative by reducing the duration of postoperative ileus, the intensity of pain and the patient's hospital stay, as well as the cost of management in our context of lack of financial, technical and human resources, hence the present study.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Postoperative Pain

Currently open trials in the same condition.

Other Université NAZI BONI trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06051630.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing